Your browser doesn't support javascript.
loading
Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes.
Wu, Hongjiang; Lau, Eric S H; Yang, Aimin; Fan, Baoqi; Ma, Ronald C W; Kong, Alice P S; Chow, Elaine; So, Wing-Yee; Chan, Juliana C N; Luk, Andrea O Y.
Afiliación
  • Wu H; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Lau ESH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Yang A; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Fan B; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
  • Ma RCW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Kong APS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Chow E; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
  • So WY; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
  • Chan JCN; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.
  • Luk AOY; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China.
Diabetes Metab Res Rev ; 39(4): e3615, 2023 05.
Article en En | MEDLINE | ID: mdl-36652944

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Diabetes Metab Res Rev Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV / Metformina Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Diabetes Metab Res Rev Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido